These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26253906)

  • 1. NSAIDs increase bleeding risk in patients with atrial fibrillation on antithrombotic therapy.
    McGrath ER
    Evid Based Med; 2015 Oct; 20(5):188. PubMed ID: 26253906
    [No Abstract]   [Full Text] [Related]  

  • 2. [NSAID in antithrombotic treatment increases risk of bleeding].
    Holzgreve H
    MMW Fortschr Med; 2015 Mar; 157(4):38. PubMed ID: 25743979
    [No Abstract]   [Full Text] [Related]  

  • 3. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
    Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH
    Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients: nonsteroidal anti-inflammatory drugs and serious bleeding and thromboembolism in patients with atrial fibrillation.
    Ann Intern Med; 2014 Nov; 161(10):I-38. PubMed ID: 25402529
    [No Abstract]   [Full Text] [Related]  

  • 5. In people with atrial fibrillation receiving antithrombotics, short-term non-steroidal anti-inflammatory drug exposure increases risk of serious bleeding.
    Myat A
    Evid Based Nurs; 2016 Jan; 19(1):11. PubMed ID: 26296961
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation.
    Lip GY
    Expert Rev Cardiovasc Ther; 2015; 13(9):963-5. PubMed ID: 26198642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy and bleeding risk in atrial fibrillation. Fewer unanswered questions.
    Ruiz-Nodar JM; Marín F
    Thromb Haemost; 2013 Mar; 109(3):363-5. PubMed ID: 23407818
    [No Abstract]   [Full Text] [Related]  

  • 9. The hemorrhagic risk: how to evaluate it.
    Di Fusco SA; Colivicchi F; Santini M
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1191-7. PubMed ID: 23663153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.
    Myat A; Ahmad Y; Haldar S; Tantry US; Redwood SR; Gurbel PA; Lip GY
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1029-49. PubMed ID: 23984927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic therapy in patients with atrial fibrillation: a comment on the European guidelines].
    Said SM; Nahrendorf W; Schmidt H; Braun-Dullaeus RC
    Dtsch Med Wochenschr; 2011 Jun; 136(25-26):1384-5. PubMed ID: 21674428
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute coronary syndrome in patients with atrial fibrillation: what is the benefit/risk profile of triple antithrombotic therapy?
    Maggioni AP
    Circulation; 2012 Sep; 126(10):1176-8. PubMed ID: 22869840
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Marín et al regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".
    Marín F; Fauchier L; Rubboli A
    Circulation; 2013 Apr; 127(17):e584. PubMed ID: 23630091
    [No Abstract]   [Full Text] [Related]  

  • 17. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".
    Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML
    Circulation; 2013 Apr; 127(17):e585. PubMed ID: 23762910
    [No Abstract]   [Full Text] [Related]  

  • 19. [Your patient needs an antithrombotic drug, 9. Atrial fibrillation: unnecessary hesitation regarding anticoagulants?].
    MMW Fortschr Med; 2013 Nov; 155 Spec No 2():24. PubMed ID: 24734444
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-related quality of life after adverse bleeding events associated with antithrombotic drug therapy - A systematic review.
    Res LCS; Lubberts B; Shah SH; DiGiovanni CW
    Hellenic J Cardiol; 2019; 60(1):3-10. PubMed ID: 29908761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.